STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #346 by analyst upside · 2026-09-09
VREOF
Vireo Growth Inc.
Healthcare · Market Cap $633M · P/E 0x
ANALYST PRICE TARGET
+266.7%
implied upside to consensus target
Current Price $12.27
Consensus Target $45.0
Bull Target $45.0
Bear Target $45.0
Analysts Covering 1
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
1
Hold
0
Sell
0
52-Week Low $8.91
52-Week High $22.5
YTD Return -32.2%
FUNDAMENTALS
Market Cap $633M
P/E Ratio (TTM) N/A
Forward P/E 6.3x
EPS (TTM) $-1.82
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $512M
Profit Margin -13.1%
52-WEEK RANGE
52-Week Low $8.91
52-Week High $22.5
Current Price $12.27
Bear Target $45.0
Bull Target $45.0
● Now $12.27 ● Target $45.0
TRADING DATA
Avg Volume 32K
YTD Return -32.2%
Analyst Count 1
Consensus Buy
Upside to Target +266.7%
Last Updated 2026-09-09

ANALYST SUMMARY

Vireo Growth Inc. (VREOF) is currently trading at $12.27 with a Wall Street consensus price target of $45.0, implying potential upside of 266.7% over the next 12 months. 1 analysts currently cover VREOF, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $45.0, while the most cautious has a target of $45.0.

VREOF operates in the Healthcare sector with a market capitalisation of $633M. The stock is down 32.2% year-to-date and is currently trading near the lower end of its 52-week range of $8.91 – $22.5.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
40
out of 100
Coverage depth
5/30
Consensus clarity
8/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →